ArticleScientific reports2024

Mcl-1 expression is a predictive marker of response to gemcitabine plus nab-paclitaxel for metastatic pancreatic cancer.

Makiko Urabe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.